We have a highly experienced Board and Senior Executive Team. The Board sets the Company’s strategy and policies, and monitors progress towards meeting our objectives. This includes regular reviews of financial performance and critical business issues. The Senior Executive Team, led by the Chief Executive Officer, focuses on the day-to-day running of our business operations and our Company development, regularly reviewing and deciding all major business issues.
Senior Executive Team
-
- Pascal Soriot
- Executive Director, Chief Executive Officer Biography
-
- Simon Lowth
- Executive Director, Chief Financial Officer Biography
-
- Menelas (Mene) Pangalos
- Executive Vice President, Innovative Medicines Biography
-
- Bahija Jallal
- Executive Vice President, MedImmune Biography
-
- Briggs Morrison
- Executive Vice President, Global Medicines Development Biography
-
- Paul Hudson
- Executive Vice President, North America Biography
-
- Ruud Dobber Ph.D.
- Executive Vice President, Europe Biography
-
- Mark Mallon
- Executive Vice President, International Biography
-
- David Smith
- Executive Vice-President, Global Operations & IS Biography
-
- Lynn Tetrault
- Executive Vice-President, Human Resources and Corporate Affairs Biography
-
- Katarina Ageborg
- Chief Compliance Officer Biography
-
- Jeff Pott
- General Counsel Biography
The Board
-
- Leif Johansson
- Non-Executive Chairman, Chairman of the Nomination and Governance Committee, member of the Remuneration Committee
Appointed 26 April 2012
-
- Pascal Soriot
- Executive Director, Chief Executive Officer
Appointed 1 October 2012
-
- Simon Lowth
- Executive Director, Chief Financial Officer
Appointed 16 November 2007
-
- John Varley
- Senior Non-Executive Director Chairman of the Remuneration Committee, member of the Nomination and Governance Committee
Appointed 26 July 2006
-
- Marcus Wallenberg
- Non-Executive Director Member of the Science Committee
Appointed 6 April 1999
-
- Dame Nancy Rothwell
- Non-Executive Director Chairman of the Science Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee
Appointed 27 April 2006
-
- Jean-Philippe Courtois
- Non-Executive Director Member of the Audit Committee
Appointed 18 February 2008
-
- Rudy Markham
- Non-Executive Director Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee
Appointed 12 September 2008
-
- Bruce Burlington
- Non-Executive Director Member of the Science Committee, member of the Audit Committee
Appointed 1 August 2010
-
- Baroness Shriti Vadera
- Non-Executive Director and member of the Audit Committee
Appointed 1 January 2011
-
- Geneviève Berger
- Non-Executive Director, Member of the Science Committee
Appointed 26 April 2012
-
- Graham Chipchase
- Non-Executive Director Member of the Audit Committee
Appointed 26 April 2012
Board Committee remits
The remits for AstraZeneca's Board Committees are available to view/download here: